25 May, 2026 | Monday | News

Global pharmaceutical company Lupin Limited announced that China's National Medical Products Administration has approved the shortened marketing authorization application for oseltamivir phosphate submitted by ...

29 May, 2026 | Friday | News

Building on the market-defining computational pathology partnership between Leica Biosystems and Indica Labs, this new collaboration integrates Lunit's advanced AI capabilities into the best-in-class IHC staini...

29 May, 2026 | Friday | News

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of oncology and hematological diseases, announced that the Center for Drug Evaluation (CDE) of China's N...

27 May, 2026 | Wednesday | News

WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that its drug substance facility (MFG23) located in Suzhou ...

27 May, 2026 | Wednesday | News

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide-gmod) 8.5 mg for the treatment of adults living with chroni...

29 May, 2026 | Friday | News

Building on the market-defining computational pathology partnership between Leica Biosystems and Indica Labs, this new collaboration integrates Lunit's advanced AI capabilities into the best-in-class IHC staini...

28 May, 2026 | Thursday | News

DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and PMA pa...